Clostridioides difficile infection leading to fulminant colitis with toxic megacolon
Fareed Rajack; Shawn Medford; Tammey Naab
Abstract
Keywords
References
1 Czepiel J, Dróżdż M, Pituch H, et al.
2 Dutta SK, Girotra M, Kumar V, et al. Clinical predictors of fulminant colitis in patients with
3 Ramai D, Dang-Ho KP, Lewis C, et al.
4 Marra AR, Perencevich EN, Nelson RE, et al. Incidence and outcomes associated with
5 Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care–associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732-44.
6 Sayedy L, Kothari D, Richards RJ. Toxic megacolon associated
7 Centers for Disease Control and Prevention (CDC).
8 Khanna S, Gupta A. Community-acquired
9 Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative
10 Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of
11 Eaton SR, Mazuski JE. Overview of severe
12 Vaishnavi C. Clinical spectrum & pathogenesis of
13 Desai J, Elnaggar M, Hanfy AA, Doshi R. Toxic megacolon: background, pathophysiology, management challenges and solutions. Clin Exp Gastroenterol. 2020;13:203-10.
14 Jalan KN, Sircus W, Card WI, et al. An experience of ulcerative colitis. Gastroenterology. 1969;57(1):68-82.
15 Ciccocioppo R, Corazza GR. In-hospital mortality for toxic megacolon. Intern Emerg Med. 2018;13(6):837-8.
16 Tomita R, Munakata K, Tanjoh K. Role of non-adrenergic non-cholinergic inhibitory nerves in the colon of patients with ulcerative colitis. J Gastroenterol. 1998;33(1):48-52.
17 Tomita R, Tanjoh K. Role of nitric oxide in the colon of patients with ulcerative colitis. World J Surg. 1998;22(1):88-92, discussion 92.
18 Pons L, Droy-Lefaix M-T, Bueno L. Leukotriene D4 participates in colonic transit disturbances induced by intracolonic administration of Trinitrobenzene sulfonic acid in rats. Gastroenterology. 1992;102(1):149-56.
19 Snape WJ Jr, Kao HW. Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci. 1988;33(3, Suppl):65S-70S.
20 Doshi R, Desai J, Shah Y, Decter D, Doshi S. Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States. Intern Emerg Med. 2018;13(6):881-7.
21 Ausch C, Madoff RD, Gnant M, et al. Aetiology and surgical management of toxic megacolon. Colorectal Dis. 2006;8(3):195-201.
22 Greenstein AJ, Sachar DB, Gibas A, et al. Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol. 1985;7(2):137-44.
23 Sailhamer EA, Carson K, Chang Y, et al. Fulminant
24 Toshniwal R, Silva J Jr, Fekety R, Kim K-H. Studies on the epidemiology of colitis due to
25 Aberra FN.
26 Bartlett JG.
27 Panos MZ, Wood MJ, Asquith P. Toxic megacolon: the knee-elbow position relieves bowel distension. Gut. 1993;34(12):1726-7.
28 Danovitch SH. Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am. 1989;18(1):73-82.
29 McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for
30 Al-Abed YA, Gray EA, Rothnie ND. Outcomes of emergency colectomy for fulminant
31 Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL. Receipt of antibiotics in hospitalized patients and risk for
32 Dubberke ER. Preventing
33 Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for
34 McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of
35 Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW.
36 Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on management of
37 Hookman P, Barkin JS.
38 McFarland LV. Update on the changing epidemiology of clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2008;5(1):40-8.
39 Guh AY, Kutty PK.
40 Al Momani LA, Abughanimeh O, Boonpherg B, Gabriel JG, Young M. Fidaxomicin vs vancomycin for the treatment of a first episode of
41 Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus Vancomycin for
42 Cornely OA, Crook DW, Esposito R, et al. Fidaxomicin versus vancomycin for infection with
43 Dutta SK, Girotra M, Garg S, et al. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent
44 Hecker MT, Obrenovich ME, Cadnum JL, et al. Fecal microbiota transplantation by freeze-dried oral capsules for recurrent
45 Fischer M, Sipe B, Cheng Y-W, et al. Fecal microbiota transplant in severe and severe-complicated
46 Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of
47 Barth H, Aktories K, Popoff MR, Stiles BG. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus Proteins. Microbiol Mol Biol Rev. 2004;68(3):373-402.
48 Leffler DA, Lamont JT.
49 McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene–variant strain of
50 Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of
51 Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181-206.
52 Salen P, Stankewicz HA. Pseudomembranous Colitis [Internet]. StatPearls; 2023 [cited 2023 July 10]. Available from:
53 Said Fadi Yassin M. Pseudomembranous colitis surgery [Internet]. Medscape; 2023 [cited 2023 July 10]. Available from:
54 Poxton IR, McCoubrey J, Blair G. The pathogenicity of
55 Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial
56 Baktash A, Terveer EM, Zwittink RD, et al. Mechanistic insights in the success of fecal microbiota transplants for the treatment of
57 Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ.
58 Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Buisson CB. Contamination of healthcare workers’ hands with
59 Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, Donskey CJ. Acquisition of spores on gloved hands after contact with the skin of patients with
60 Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol. 2002;23(12, Suppl):S3-40.
61 Turner NA, Anderson DJ. Hospital infection control:
62 Stone SP, Fuller C, Savage J, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012;344:e3005.
63 Vital signs: preventing
64 Gupta A, Ananthakrishnan AN. Economic burden and cost-effectiveness of therapies for
Submitted date:
08/08/2023
Accepted date:
10/14/2023
Publication date:
11/16/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email